SubHero Banner
Text

1st Quarter 2019

Key topics in this quarter’s edition include:

  • Esketamine: treatment-resistant depression
  • Onasemnogene abeparvovec (Zolgensma): treatment of spinal muscular atrophy type 1
  • NKTR-181: treatment of chronic low back pain

Download PDF

Text